Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Equity Average (2022 - 2025)

Historic Equity Average for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$18.8 million.

  • Envoy Medical's Equity Average fell 2125.13% to -$18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.8 million, marking a year-over-year decrease of 2125.13%. This contributed to the annual value of -$10.3 million for FY2024, which is 4570.07% up from last year.
  • Envoy Medical's Equity Average amounted to -$18.8 million in Q3 2025, which was down 2125.13% from -$27.0 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Equity Average ranged from a high of $1.5 million in Q4 2023 and a low of -$46.3 million during Q2 2023
  • In the last 4 years, Envoy Medical's Equity Average had a median value of -$19.8 million in 2022 and averaged -$20.8 million.
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 10562.13% in 2023, then tumbled by 134202.66% in 2024.
  • Envoy Medical's Equity Average (Quarter) stood at -$26.8 million in 2022, then surged by 105.62% to $1.5 million in 2023, then tumbled by 1342.03% to -$18.7 million in 2024, then fell by 0.36% to -$18.8 million in 2025.
  • Its last three reported values are -$18.8 million in Q3 2025, -$27.0 million for Q2 2025, and -$21.5 million during Q1 2025.